UK trebles chlamydia screening among 15-24 age group
This article was originally published in Clinica
The rate of chlamydia screening among people aged 15-24 years in the UK has more than trebled in the last year, according to the healthcare watchdog, the Care Quality Commission (CQC). In the year to April 2009, 16% of this segment of the population were screened, compared with 5% the previous year. The CQC has highlighted the fact in its NHS Ratings 2008-09 report as one of the top five "positive improvements for patients".
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.